Dudediligence.

Zoetis Inc

ZTSNYSE · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$2.39BSep ’24$2.32BDec ’24$2.20BMar ’25$2.46BJun ’25$2.40BSep ’25$2.39BDec ’25$2.26BMar ’26$2.47BJun ’26
Net income, by quarter
$682.0MSep ’24$581.0MDec ’24$602.0MMar ’25$718.0MJun ’25$721.0MSep ’25$603.0MDec ’25$601.0MMar ’26$691.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$7.78B$8.08B$8.54B$9.26B$9.47B
Gross profit$5.47B$5.63B$5.98B$6.54B$6.80B
Net income$2.04B$2.11B$2.34B$2.49B$2.67B
Operating cash flow$2.21B$1.91B$2.35B$2.95B$2.90B
Free cash flow$1.74B$1.33B$1.62B$2.30B$2.28B
Cash$3.48B$3.58B$2.04B$1.99B$2.45B
Debt$6.59B$7.90B$6.56B$6.57B$9.04B
Shares outstanding472.6M463.8M458.4M448.5M424.9M